(Q45191304)

English

The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues

scientific article published on 5 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

11

object named as

Masaaki Oka

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

author name string

Naoko Okayama

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Mitsuaki Nishioka

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Shoichi Hazama

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Kouhei Sakai

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Yutaka Suehiro

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Masato Maekawa

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Jun-ichi Sakamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Shigeyoshi Iwamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Takeshi Kato

9

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Hideyuki Mishima

10

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Yuji Hinoda

12

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

publication date

5 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

165-171

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Effect of buffered formalin on amplification of DNA from paraffin wax embedded small biopsies using real-time PCR.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Retrospective DNA analysis using fixed tissue specimens

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Comparison of methods in the recovery of nucleic acids from archival formalin-fixed paraffin-embedded autopsy tissues

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

DNA amplification from formalin-fixed decalcified paraffin-embedded bone marrow trephine specimens: does the duration of storage matter?

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Effect of fixation to the degradation of nuclear and mitochondrial DNA in different tissues

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Polymorphisms of DNA repair genes are risk factors for prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ173

21 January 2018

Identifiers

10.1093/JJCO/HYQ173

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45191304&oldid=2069440944"